GSK has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
No ownership data available.
|Insider||Position||Date||Buy/Sell||Shares||Shares Owned Following This (Direct & Indirect)||Trade Price ($)||Cost ($1000)||Price Change
Since Trade (%)
|Share Ownership Details|
|GLAXOSMITHKLINE PLC||Former 10% Owner||2015-02-23||Sell||503,150||1,436,448||$22||11069.3||91.55|
1,436,448 (By S.R. One Limited)
|GLAXOSMITHKLINE PLC||10% Owner||2014-12-18||Sell||50,000||1,939,598||$21.14||1057||99.34|
1,939,598 (By S.R. One Limited)
|GLAXOSMITHKLINE PLC||Former 10% Owner (1)||2014-10-27||Sell||11,315,825||0||$5.29||59860.7||696.6|
0 (By Corporation)
|GLAXOSMITHKLINE PLC||10% Owner||2014-04-01||Buy||103,762||1,989,598||$12||1245.1||251.17|
1,989,598 (By S.R. One Limited)
|GLAXOSMITHKLINE PLC||Former 10% Owner||2014-02-19||Buy||35,000||2,678,066||$14||490||201|
1,356,533 (By S.R. One Limited)
1,321,533 (By Glaxo Group Limited)
|GLAXOSMITHKLINE PLC||Former 10% Shareholder||2014-02-10||Buy||143,773||1,671,667||$12||1725.3||251.17|
1,671,667 (See Footnote)
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as Conversion of derivative security or Exercise of Options are not included. Insiders are only limited to Officers and/or Directors of the company.